Turkey has “spent $123.34 million with the largest and the most technologically advanced industrial investments up until now in Turkey’s pharmaceutical industry,” the deputy health minister says. Chickenpox, Hepatitis A vaccine top priorities, says Turkey’s Deputy Health Minister Emine Alp Mese. “The Turkish Health Ministry has called on local pharmaceutical firms to produce these vaccines,” Emine Alp Mese said.
She made the remarks during a visit to Onko and Kocsel, a local cancer drug manufacturer, in Turkey’s industrial province of Kocaeli. Mese went on to say that they will first focus on vaccinations against chickenpox and Hepatitis A, as they take up the lion’s share in health spending. “We have been in contact with foreign academics for the last three to four months about the production of these vaccines,” she added.
She also noted that domestic production and export of cancer drugs is important as they will bring home foreign exchange. Tugba Koc, a board member of Onko and Kocsel, said they could prepare a chickenpox vaccine within three to four years.